With respect to group EE, the nuclear Nrf2 and HO-1 levels were amplified by AF treatment in a dose-dependent mode, while this effect was apparently overturned by combined therapy of AF and LY294002. This evidence concerns the gene HMOX1 and atrial fibrillation.